Causeway Emerging Markets Fund NSE:AUROPHARMA Holdings History
Causeway Emerging Markets Fund's Aurobindo Pharma Ltd Holding Summary
As of 2025-03-31, CAUSEWAY CAPITAL MANAGEMENT TRUST held 92,182.00 shares of Aurobindo Pharma Ltd(NSE:AUROPHARMA), totaling ₹1.25 Mil. This investment constitutes 0.07% of their stock portfolio, and CAUSEWAY CAPITAL MANAGEMENT TRUST now holds 0.02% of the outstanding Aurobindo Pharma Ltd(NSE:AUROPHARMA) stock.
The initial trade took place in 2019Q3. And since then Causeway Emerging Markets Fund has made 6 purchases of NSE:AUROPHARMA, at an average price of ₹756.08, for a total of 4.07 Mil shares. In addition, there have been 7 sales at an average price of ₹879.58 for 3.98 Mil shares. Based on historical transaction data and NSE:AUROPHARMA's current price of ₹1114.10, Causeway Emerging Markets Fund's estimated gain on his NSE:AUROPHARMA holdings is ₹524.86 Mil, reflecting a 17.04% gain to date.
Causeway Emerging Markets Fund NSE:AUROPHARMA (₹1114.10) Holding Chart
Causeway Emerging Markets Fund NSE:AUROPHARMA (₹1114.10) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price ₹-/Share | ||
Shares Sold | 0 | Average Price ₹-/Share | ||
Current Price ₹0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1